Is Henry Schein Stock Underperforming the Nasdaq?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 01 2025
0mins
Source: NASDAQ.COM
Company Overview: Henry Schein, Inc. is a global healthcare solutions provider with a market cap of $8.5 billion, primarily serving dental and medical professionals, and has experienced a decline in stock value despite reporting a revenue increase in its fourth-quarter results.
Market Performance: The company's shares have underperformed compared to the Nasdaq Composite, with a 16.3% drop from its 52-week high, while analysts maintain a "Moderate Buy" rating with a price target suggesting potential growth.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
